Ligand profile
FMP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_5132 — AMP nucleosidase
Identifiers
Database identifiers and provenance.
- Ligand ID
FMP- PDB
1t8s- UniProt (similar protein)
P0AE12- Target protein
- VK055_5132
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 196.9
- −1 ≤ LogP ≤ 5 -1.79
- MW ≤ 500 Da 347.2
- LogP ≤ 5 -1.79
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 196.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc2c(c(n1)N)[nH]nc2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)Oc1nc2c(c(n1)N)[nH]nc2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O
InChI=1S/C10H14N5O7P/c11-10-6-4(12-2-13-10)5(14-15-6)9-8(17)7(16)3(22-9)1-21-23(18,19)20/h2-3,7-9,16-17H,1H2,(H,14,15)(H2,11,12,13)(H2,18,19,20)/t3-,7-,8-,9+/m1/s1InChI=1S/C10H14N5O7P/c11-10-6-4(12-2-13-10)5(14-15-6)9-8(17)7(16)3(22-9)1-21-23(18,19)20/h2-3,7-9,16-17H,1H2,(H,14,15)(H2,11,12,13)(H2,18,19,20)/t3-,7-,8-,9+/m1/s1
PBAHXXBYQACZMA-KSYZLYKTSA-NPBAHXXBYQACZMA-KSYZLYKTSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01048
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand FMP →
- PDB RCSB structure 1t8s →
- UniProt UniProt P0AE12 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “FMP”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_5132.
ZINC 31
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).